Edwin Gomez
Psychiatry · Weston, FLNPI 1780775098
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.8%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Neurocrine Biosciences, Inc. at 27.5% of the total.
Across 122 payments — averaging $45.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$2K
- Boehringer Ingelheim$1K
- E.r. Squibb & Sons, L.L.C.$754
- Otsuka America Pharmaceutical, Inc.$379
- Alkermes, Inc.$365
- Indivior Inc.$364
- plus $959 from 9 others
Across 631 payments — averaging $39,486 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Teva Pharmaceuticals USA, Inc.$14.4M
- E.r. Squibb & Sons, L.L.C.$7.1M
- Sumitomo Pharma America, Inc.$1.9M
- Vanda Pharmaceuticals Inc.$624K
- AbbVie$308K
- Indivior Inc.$212K
- plus $351K from 7 others
What the payments were for
- Consulting fees$72013%
- Travel & lodging$1,96235%
- Food & beverage$2,88852%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 13 | $1,534 |
| Boehringer Ingelheim | 11 | $1,223 |
| E.r. Squibb & Sons, L.L.C. | 2 | $754 |
| Otsuka America Pharmaceutical, Inc. | 17 | $379 |
| Alkermes, Inc. | 19 | $365 |
| Indivior Inc. | 16 | $364 |
| Johnson & Johnson | 13 | $224 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $177 |
| AbbVie | 8 | $125 |
| Novartis | 1 | $120 |
| Abbott | 1 | $99 |
| Teva Pharmaceuticals USA, Inc. | 7 | $83 |
| Vanda Pharmaceuticals Inc. | 3 | $65 |
| Ironshore Pharmaceuticals Inc. | 3 | $50 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COBENFY$720
- ABILIFY MAINTENA$125
- CAPLYTA$125
- SUBLOCADE$107
How this compares
$5,578 in reported general payments places this provider in the 85th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in Weston
- Andrew CutlerLakewood Ranch$5.7M
- Richard JacksonBoca Raton$3.6M
- Ilan MelnickCoral Gables$2.8M
- Todd BroderSt Augustine$1.6M
- Heather LuingSaint Augustine$1.5M
- Todd GatesWest Melbourne$1.2M
- Lawrence ReccoppaGainesville$968K
- Thomas ValenteLeesburg$967K
- Michelle ScargleClearwater$926K
- David SheehanTampa$631K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.